Stimusil 

A novel hair regrowth system for clinicians

OWNER

Pablo Villalba (See Profile)


Sector

Medical Device

Stage

Development, market readiness, clinical trial

Country

USA


Non-invasive Alternative to Hair Transplants

FDA Approval / CE Mark expected in 2024

Patented tech applicable to more Aesthetic Indication

Status

Approved

IP Type

PCT

Time

15 years

Countries

USA

Coverage

Dermal Light Delivery
Multiple Indications

Status

Pending

IP Type

Patent

Time

–

Countries

Belgium
France
Germany
Italy
Netherlands
Spain
USA
United Kingdom

Coverage

Laser Alignment System
Required safety features
Optimal configurations

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: 7th of February 2023

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar